Leadership Series

Economic Intelligence for Patient Financial Performance

This ten-essay Leadership Series establishes Economic Intelligence as the financial science of patient financial performance-the discipline that determines the economic objective, financial pathway, and attainable patient-provider value before RCM, AI, payment plans, financing, assistance, collections, or enterprise platforms act.

Rethinking a Market Category Built for Execution, Not Economic Performance

Why patient financial performance needs Economic Intelligence before execution.

The Patient-Provider Revenue Curve (ARxCurve™)

Why the balance is not the strategy—expected yield is.

AI Cannot Optimize What Patient Financial Performance Has Not Defined

Why patient-financial AI requires the right economic objective before it acts.

Patient-Payment Denials: The Revenue Failures Healthcare Has Not Yet Defined

Using Economic Intelligence to Create a Patient-Nonpayment Denial Taxonomy

The Patient Financing Fit Test

An Economic Intelligence Standard for Evaluating Financing Across Affordability, Access, Revenue, and Cash Acceleration

Drone RCM Across Patient Financial Performance

Precision economic intelligence for the super-platform era.

Beyond FPL: Economic Intelligence for Financial Assistance

The Residual-Viability Test for Aligning Assistance with Actual Patient Need

Resolving the Upfront Collection Paradox

How Economic Intelligence Maximizes Total Patient Revenue Across the Financial Encounter

The Rise, Overreach, and Reinvention of Propensity Scoring

Repositioning a directional signal within Economic Intelligence.

Extending the Utility of Price Transparency

How Economic Intelligence converts price disclosure into financial clarity and an e-commerce capability.